Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 2
1950 1
1951 2
1952 6
1953 5
1957 1
1958 1
1976 1
1978 2
1979 2
1980 1
1993 1
1994 3
1995 2
1998 1
1999 2
2000 5
2001 3
2002 6
2003 3
2004 9
2005 7
2006 4
2007 4
2008 4
2009 9
2010 7
2011 8
2012 7
2013 9
2014 12
2015 9
2016 6
2017 6
2018 11
2019 8
2020 7
2021 9
2022 12
2023 14
2024 21
2025 21

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

223 results

Results by year

Filters applied: . Clear all
Page 1
La territorializzazione del farmaco in epoca di PNRR: prospettive, opportunità e spunti di riflessione da un panel di esperti.
Marata AM, Marrocco W, Arcangeli E, Battistini M, Buzzetti G, Candido R, Casadei G, Cattel F, Cavaliere A, Consoli A, Corrao G, Didoni G, Di Gesù M, Giovanzana A, Lenzi M, Medaglia M, Meloncelli M, Palcic S, Pani M, Patarnello F, Pria E, Scaduto D, Tozzi V, Zibellini M, Crovato E. Marata AM, et al. Among authors: candido r. Glob Reg Health Technol Assess. 2022 Dec 5;9:155-158. doi: 10.33393/grhta.2022.2495. eCollection 2022 Jan-Dec. Glob Reg Health Technol Assess. 2022. PMID: 36628310 Free PMC article. Italian.
Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials.
Mannucci E, Nreu B, Montereggi C, Ragghianti B, Gallo M, Giaccari A, Monami M; SID-AMD joint panel for Italian Guidelines on Treatment of Type 2 Diabetes. Mannucci E, et al. Nutr Metab Cardiovasc Dis. 2021 Sep 22;31(10):2745-2755. doi: 10.1016/j.numecd.2021.06.002. Epub 2021 Jul 5. Nutr Metab Cardiovasc Dis. 2021. PMID: 34364771 Free article.
Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care.
Morieri ML, Candido R, Frontoni S, Disoteo O, Solini A, Fadini GP; PIONEERING EXPERIENCE study group. Morieri ML, et al. Among authors: candido r. Diabetes Ther. 2023 Dec;14(12):2159-2172. doi: 10.1007/s13300-023-01490-6. Epub 2023 Oct 18. Diabetes Ther. 2023. PMID: 37848758 Free PMC article.
Italian guidelines for the treatment of type 2 diabetes.
Mannucci E, Candido R, Delle Monache L, Gallo M, Giaccari A, Masini ML, Mazzone A, Medea G, Pintaudi B, Targher G, Trento M, Turchetti G, Lorenzoni V, Monami M; for Società Italiana di Diabetologia (SID) and Associazione Medici Diabetologi (AMD). Mannucci E, et al. Among authors: candido r. Nutr Metab Cardiovasc Dis. 2022 Apr;32(4):770-814. doi: 10.1016/j.numecd.2022.01.027. Epub 2022 Feb 4. Nutr Metab Cardiovasc Dis. 2022. PMID: 35227550 Free article. No abstract available.
Lipid-lowering therapy and LDL target attainment in type 2 diabetes: trends from the Italian Associations of Medical Diabetologists database.
Rossi A, Masi D, Zilich R, Baccetti F, Baronti W, Falcetta P, Morviducci L, Musacchio N, Muselli M, Ozzello A, Salomone E, Verda D, Vezenkova M, Candido R, Ponzani P. Rossi A, et al. Among authors: candido r. Cardiovasc Diabetol. 2025 Feb 28;24(1):94. doi: 10.1186/s12933-025-02648-1. Cardiovasc Diabetol. 2025. PMID: 40022078 Free PMC article.
223 results